Regulation of NMDA receptor trafficking by amyloid-β
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This synaptotoxicity is associated with a reduction in the surface expression of various receptor proteins, including those forming the N-methyl-D-aspartate receptors [26,27], which are critical for generation of long-term potentiation in hippocampal synapses.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“Oligomeric Aβ species have been shown to cause memory deficits in rodents [25] and are known for their synaptotoxic properties.”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [27]
In the citing paper
“It has been previously reported that extracellular application of Ab oligomers to primary neuronal cultures or organotypic hippocampal slices induce rapid changes in the structure and density of synaptic spines 47,48 and reduces expression of NMDARs and related synaptic proteins, 49 through several signaling pathways, one of which involves the a-7 nicotinic receptor.49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [49]
In the citing paper
“Indeed Aβ production and amyloid production has been shown to reduce cell surface levels of other proteins including the NMDA receptor and the EphB2 receptor, both involved in synaptic plasticity [57], [58].”
From LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease (2010) · cites this paper as [57]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Results Amyloid-β decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-β regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor current”
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Reinsertion or Degradation of AMPA Receptors Determined by Activity-Dependent Endocytic Sorting
Ehlers, M. D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00129-x · Cited by 1,096
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
Cited by
Items 901–1,000 of 1,006
Alterations of some membranetransportproteins in Alzheimer's disease: role of amyloid β-peptide
Sultana, R., & Butterfield, D. A. (2007) · Molecular BioSystems · doi:10.1039/b715278g · Cited by 33
Darcq, E., Hamida, S. B., Wu, S., Phamluong, K., Kharazia, V., Xu, J., Lombroso, P. J., & Dorit Ron, A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12701 · Cited by 28
“Both Fyn (Nguyen et al. 2002) and GluN2B (Snyder et al. 2005) are substrates of the membranal associated form of STEP, e.g., STEP61, and the phosphatase regulates the phosphorylation-dependent enhancement of channel activity (Pelkey et al. 2002).”
BackgroundInfluentialSelf-citationOren, O., Ben-Zichri, S., Taube, R., Jelinek, R., & Papo, N. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00638 · Cited by 27
Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats
Gomaa, A. A., Makboul, R. M., El‐Mokhtar, M. A., Abdel‐Rahman, E. A., Ahmed, E. A., & Nicola, M. A. (2020) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12585 · Cited by 28
Zhang, L., Qin, Z., Sharmin, F., Lin, W., Ricke, K. M., ZASLOFF, M. A., Stewart, A. F. R., & Chen, H. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105402 · Cited by 28
Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View
Huffels, C. F. M., Middeldorp, J., & Hol, E. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03699-6 · Cited by 30
Mahaman, Y. A. R., Feng, J., Huang, F., Salissou, M. T. M., Wang, J., Liu, R., Zhang, B., Li, H., Zhu, F., & Wang, X. (2022) · Nutrients · doi:10.3390/nu14204284 · Cited by 35
Zhou, C., Sun, H., Klein, P., & Jensen, F. E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00362 · Cited by 30
“, 2009; Salter and Kalia, 2004) or endocytosis (such as GluN2B at Y1472; Snyder et al., 2005) and enhance/influence GluN functions (Zahavi et al.”
Geng, D., Kang, L., Su, Y., Jia, J., Ma, J., Li, S., Du, J., & Cui, H. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.016 · Cited by 29
Tashev, R. E., de Moura, P. J., Venkitaramani, D. V., Prosperetti, C., Centonze, D., Paul, S., & Lombroso, P. J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.008 · Cited by 31
Self-citationZhang, M., Wang, Y., Qian, F., Li, P., & Xu, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.016 · Cited by 29
Zhu, L., Yang, L., Zhao, X., Liu, D., Guo, X., Liu, P., Chi, T., Ji, X., & Zou, L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4775-6 · Cited by 28
Fyn depletion ameliorates tauP301L-induced neuropathology
Liu, G., Fiock, K. L., Levites, Y., Golde, T. E., Hefti, M. M., & Lee, G. S. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00979-6 · Cited by 33
Guidi, M., Rani, A., Karic, S., Severance, B., Kumar, A., & Foster, T. C. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.07.015 · Cited by 28
“…β-amyloid (Aβ) impairs synaptic plasticity (Walsh et al., 2002; Shankar et al., 2007; Shankar et al., 2008) and rapidly decreases NMDAR responses (Snyder et al., 2005; Lacor et al., 2007; Dewachter et al., 2009), which may contribute to the onset of memory deficits associated with the early…”
Chang, L., Zhang, Y., Liu, J., Song, Y., Lv, A., Li, Y., Zhou, W., Yan, Z., Almeida, O. F. X., & Wu, Y. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150942 · Cited by 33
“Dysregulated NMDAR subunit trafficking has been suggested as a mechanism that contributes to synaptic dysfunction in AD [26].”
Jaye, S., Sandau, U. S., & Saugstad, J. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1378576 · Cited by 26
Nomura, J., Jaaro-Peled, H., Lewis, E. M., Nunez‐Abades, P., Huppé‐Gourgues, F., Cash-Padgett, T. V., Emiliani, F. E., Kondo, M., Furuya, A., Landek‐Salgado, M. A., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.61 · Cited by 29
Hu, W., He, Z., Yang, L., Zhang, M., Xing, D., & Xiao, Z. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13048 · Cited by 29
“This result is different from the previous report that the application of Aβ promotes NMDA receptor endocytosis in cortical neurons (Snyder et al., 2005).”
Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices
Nomura, I., Takechi, H., & Kato, N. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00589.2011 · Cited by 28
Xie, Z., Shi, M., Zhang, C., Zhao, H., Hui, H., & Zhao, G. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1930-0 · Cited by 29
Modified Glutamatergic Postsynapse in Neurodegenerative Disorders
Moraes, B. J., Coelho, P., Fão, L., Ferreira, I. L., & Rego, A. C. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.12.002 · Cited by 30
Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer’s Disease
Song, J., Yang, X., Zhang, M., Wang, C., & Chen, L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210595 · Cited by 26
Akwa, Y., Malta, C. D., Zallo, F., Gondard, E., Lunati, A., Diaz-de-Grenu, L. Z., Zampelli, A., Boiret, A., Santamaria, S., Martinez-Preciado, M., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2095791 · Cited by 28
“Of note, activation of PPP3/ calcineurin at synapses has been demonstrated to induce NMDA receptor endocytosis via dephosphorylation at Tyr1472 [61]; this event would be in contrast with the NMDA-induced excitatory post-synaptic current induced by the gLTP protocol [62].”
Castillo-Vázquez, S. K., Massieu, L., Rincón-Heredia, R., la Torre, P. G.-D., Quiroz‐Baez, R., Gómez-Verján, J. C., & Rivero-Segura, N. A. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.103039 · Cited by 30
Logan, S. M., Sarkar, S. N., Zhang, Z., & Simpkins, J. W. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.038 · Cited by 29
“Soluble synthetic Aβ oligomers and dimers isolated from Alzheimer’s patients, decrease cell surface expression of NMDAR and AMPAR, inhibit LTP, inhibit phosphorylation of CaMKII, ERK, and GluR1, and decrease spine density (Snyder et al., 2005; Shrestha et al., 2006).”
Chung, C. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0113-y · Cited by 31
“LTP and LTD occur in an NMDAR-dependent manner in the hippocampus, a structure deeply implicated for learning and memory.”
BackgroundMethodInfluentialJung, W. R., Kim, H. G., Shin, M. K., Park, D. I., & Kim, K. L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.012 · Cited by 27
Suina, K., Tsuchihashi, K., Yamasaki, J., Kamenori, S., Shintani, S., Hirata, Y., Okazaki, S., Sampetrean, O., Baba, E., Akashi, K., et al. (2018) · Cancer Science · doi:10.1111/cas.13826 · Cited by 27
Cline, E. N., Das, A., Bicca, M. A., Mohammad, S. N., Schachner, L. F., Kamel, J. M., DiNunno, N., Weng, A., Paschall, J. D., Bu, R. L., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14647 · Cited by 30
Amyloid Beta Secreted during Consolidation Prevents Memory Malleability
Finnie, P. S. B., & Nader, K. (2020) · Current Biology · doi:10.1016/j.cub.2020.02.083 · Cited by 32
Uemura, K., Kuzuya, A., Aoyagi, N., Andō, K., Shimozono, Y., Ninomiya, H., Shimohama, S., & Kinoshita, A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.022 · Cited by 32
Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline
Lane, H., Wang, S., & Lin, C. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115288 · Cited by 30
Lazcano, Z., Solís, Ó., Bringas, M. E., Limón, I. D., Díaz, A., Espinosa, B., García‐Peláez, I., Flores, G., & Guevara, J. (2014) · Synapse · doi:10.1002/syn.21770 · Cited by 28
“Furthermore, the NMDA receptor acts either as a selective substrate of Ab binding or as a mediator of Ab-triggered glutamate excitotoxicity (Snyder et al., 2005).”
Laurent, G. S., Faghihi, M. A., & Wahlestedt, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.032 · Cited by 26
Freund, R. K., Gibson, E. S., Potter, H., & Dell’Acqua, M. L. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.103085 · Cited by 25
“However, our data here are not consistent with any acute effect of Ab(1–42) or monastrol on synaptic NMDARs being responsible for LTP inhibition, as 20 minutes of preincubation with Ab(1–42) or monastrol was sufficient to inhibit LTP but had no significant impact on pharmacologically isolatedN-methyl-D-aspartate fEPSP…”
InfluentialSeeing Early Signs of Alzheimer's Disease Through the Lens of the Eye
Reed, B., Béhar‐Cohen, F., & Krantic, S. M. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160819131904 · Cited by 29
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 31
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
Barrera-Ocampo, A. A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.034 · Cited by 32
“A decreased expression of NMDA receptors can be attributed to neuronal death caused by excitotoxicity, which can be triggered by increased calcium influx, impaired energy metabolism, and mitochondrial damage 88 .”
BackgroundInhibition of clathrin-mediated endocytosis prevents amyloid β-induced axonal damage
Kuboyama, T., Lee, Y., Nishiko, H., & Tohda, C. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.005 · Cited by 31
Mitchell, R. M., Neafsey, E. J., & Collins, M. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06351.x · Cited by 26
Recent advances in distal myopathy with rimmed vacuoles (DMRV) or hIBM: treatment perspectives
Malicdan, M. C. V., Noguchi, S., & Nishino, I. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830dd595 · Cited by 25
DiChiara, T., DiNunno, N., Clark, J. R., Bu, R. L., Cline, E. N., Rollins, M. G., Gong, Y., Brody, D. L., Sligar, S. G., Velasco, P. T., et al. (2017) · PubMed Central · Cited by 32
Calcium Signaling During Brain Aging and Its Influence on the Hippocampal Synaptic Plasticity
Kumar, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12457-1_39 · Cited by 28
Kokubo, H., Kayed, R., Glabe, C. G., Staufenbiel, M., Saido, T. C., Iwata, N., & Yamaguchi, H. (2009) · International Journal of Alzheimer s Disease · doi:10.4061/2009/689285 · Cited by 28
The role of parvalbumin interneuron dysfunction across neurodegenerative dementias
Smeralda, C. L., Pandit, S., Turrini, S., Reilly, J., Palmisano, A., Sprugnoli, G., Hampel, H. J., Benussi, A., Borroni, B., Press, D. Z., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102509 · Cited by 27
Melatonin in Synaptic Impairments of Alzheimer’s Disease
Shi, Y., Fang, Y., Wei, Y., Jiang, Q., Zeng, P. H., Tang, N., Lu, Y., & Tian, Q. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171178 · Cited by 27
“This interaction is thought to contribute to the internalization of NMDARs through a calcineurindependent pathway [67, 69].”
β-amyloid and glutamate receptors
Gasparini, L., & Dityatev, A. E. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.005 · Cited by 28
Kroker, K. S., Moreth, J., Kußmaul, L., Rast, G. F., & Rosenbrock, H. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.04.006 · Cited by 27
Díaz, A., Jesús, L. D., Mendieta, L., Calvillo, M., Espinosa, B., Zenteno, E., Guevara, J., & Limón, I. D. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.087 · Cited by 25
Brain amyloid β protein and memory disruption in Alzheimer’s disease
Xia, W. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s7460 · Cited by 28
“α-7 nicotinic receptors (nAChRs), protein phosphatase 2B and the striatal-enriched protein (STEP) tyrosine phosphatase that are required for endocytosis of NMDA receptors; which is correlated to the dephosphorylation of the NMDA receptor-2B at Tyr1472.(35) Aβ has been shown to inhibit NMDA receptor dependent LTP altho…”
BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome
Saavedra, A., Puigdellívol, M., Tyebji, S., Kurup, P. K., Xu, J., Ginés, S., Alberch, J., Lombroso, P. J., & Pérez‐Navarro, E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9335-7 · Cited by 27
“(NMDA) glutamate receptor subunit GluN2B [18, 19] and extracellular signal-regulated kinase 1/2 (ERK1/2) [20, 21].”
Self-citationKotagale, N. R., Vinchurney, M. D., Garmelwar, H., Bhondekar, S., Umekar, M. J., & Taksande, B. G. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172976 · Cited by 25
Modeling Neurotransmission: Computational Tools to Investigate Neurological Disorders
Gandolfi, D., Boiani, G. M., Bigiani, A., & Mapelli, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094565 · Cited by 32
Budvytytė, R., & Valinčius, G. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220434 · Cited by 25
Kittler, J. T., & Moss, S. J. (2006) · CRC Press eBooks · doi:10.1201/9780203486283-9 · Cited by 23
Trebbastoni, A., Gilio, F., D’Antonio, F., Cambieri, C., Ceccanti, M., de Lena, C., & Inghilleri, M. (2011) · Clinical Neurophysiology · doi:10.1016/j.clinph.2011.09.010 · Cited by 25
Mukherjee, S., Poddar, R., Deb, I., & Paul, S. (2011) · Biochemical Journal · doi:10.1042/bj20110240 · Cited by 25
Self-citationSuo, Z., Yang, X. Z., Li, L., Liu, Y.-N., Shi, L., & Hu, X. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.015 · Cited by 25
Sun, Y., Cai, W., Yu, J., Liu, S., Zhuo, M., Li, B., & Zhang, X. (2016) · Scientific Reports · doi:10.1038/srep30743 · Cited by 25
Hernández, E. R., Mendieta, L., Flores, G., & Limón, I. D. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.11.001 · Cited by 25
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1007 · Cited by 30
Illuminating Neural Circuits in Alzheimer’s Disease
Yang, Y., & Wang, J. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00716-6 · Cited by 27
Klein, W. L., Lacor, P. N., Felice, F. G. D., & Ferreira, S. T. (2007) · Research and perspectives in neurosciences · doi:10.1007/978-3-540-45702-2_11 · Cited by 25
Martinez, T. A., Larsen, M. E., Sullivan, E. J., Woolfrey, K. M., & Dell’Acqua, M. L. (2024) · eNeuro · doi:10.1523/eneuro.0175-23.2024 · Cited by 30
Cell type-specific functions of Alzheimer's disease endocytic risk genes
Maninger, J.-K., Nowak, K., Goberdhan, S., O'Donoghue, R., & Connor-Robson, N. (2024) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2022.0378 · Cited by 22
“Reduced APOER2 receptor recycling accordingly impacts reelin-mediated NMDA activity and enhances A β -mediated NMDA-suppression, which is counteracted by increasing the IEP differential between APOE4 and EE through NHE6 inhibition [141,143].”
BackgroundThe Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 22
Bono, F., Fiorentini, C., Mutti, V., Tomasoni, Z., Sbrini, G., Trebesova, H., Marchi, M., Grilli, M., & Missale, C. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106711 · Cited by 26
“A physio-pathological significance of this interaction was indicated by Snyder and colleagues who showed that β -amyloid regulated NMDAR trafficking through interaction with the α 7 receptors [157].”
Horvat-Broecker, A., Reinhard, J., Illes, S., Paech, T., Zoidl, G., Harroch, S., Distler, C., Knyazev, P. G., Ullrich, A., & Faissner, A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.016 · Cited by 22
Morin, J., Cerón-Solano, G., Velázquez-Campos, G., Pacheco‐López, G., Bermúdez‐Rattoni, F., & Díaz-Cintra, S. Y. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150975 · Cited by 24
“In AD models, hippocampal synaptic dysfunction was shown to correlate with cognitive impairment and proposed as an early event in the pathogenesis of AD in which A is believed to play a central role [6, 7].”
BackgroundCho, Y., Kim, H., Kim, W., Chung, S., Kim, Y.-H., Cho, I., Lee, B. I., & Heo, K. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.08.003 · Cited by 22
Tjin, C. C., Otley, K. D., Baguley, T. D., Kurup, P. K., Xu, J., Nairn, A. C., Lombroso, P. J., & Ellman, J. A. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00486 · Cited by 22
Self-citationHuang, F., Qu, A., Yang, H., Zhu, L., Zhou, H., Liu, J., Long, J., & Shi, L. (2018) · ACS Macro Letters · doi:10.1021/acsmacrolett.8b00495 · Cited by 22
Kedia, S., Ramakrishna, P., Netrakanti, P. R., Singh, N., Sisodia, S. S., Jose, M., Kumar, S., Mahadevan, A., Ramanan, N., Nadkarni, S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101924 · Cited by 24
Mahaman, Y. A. R., Huang, F., Embaye, K. S., Wang, X., & Zhu, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.680118 · Cited by 23
“Besides, it can also lead to the dephosphorylation and internalization of synaptic receptor complexes like GluN2B/GluN1 and GluA2/GluA1 subunits of NMDA and AMPA receptors, respectively (Snyder et al., 2005; Zhang et al., 2008; Poddar et al., 2010; Wu et al., 2011).”
BackgroundResultInfluentialSTEP regulation of seizure thresholds in the hippocampus
Briggs, S. W., Walker, J., Asik, K., Lombroso, P. J., Naegele, J. R., & Aaron, G. B. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02912.x · Cited by 24
“STEP dephosphorylates the N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B at tyr(1472), which promotes internalization of the GluN1/GluN2B receptor complex (Snyder et al., 2005; Kurup et al., 2010b).”
Self-citationKelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 30
“Similar to Aβ, aging impairs basal synaptic transmission and induces NMDAR-dependent inhibition of LTP by disrupting intracellular Ca 2+ signaling (Foster and Norris 1997).”
InfluentialWu, P. H., Coultrap, S. J., Browning, M. D., & Proctor, W. R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06991.x · Cited by 21
Therapeutic Approaches of Leptin in Alzheimers Disease
Carro, E. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909789104848 · Cited by 21
Lei, G., Anastasio, N. C., Fu, Y., Neugebauer, V., & Johnson, K. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06030.x · Cited by 21
From understanding synaptic plasticity to the development of cognitive enhancers
Cheung, Z. H., & Ip, N. Y. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001537 · Cited by 22
“In addition, antidepressant treatment enhances the expression of BDNF and transcription factor CREB, which have been demonstrated as pivotal players in long-term synaptic plasticity Downloaded from https://academic.oup.com/ijnp/article-abstract/14/9/1247/649371 by guest on 28 July 2018 (Chen et al. 2001; Thome et al.…”
InfluentialJang, S.-S., Royston, S. E., Lee, G., Wang, S., & Chung, H. J. (2016) · Neural Plasticity · doi:10.1155/2016/2123748 · Cited by 26
Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease
Gamage, K. K., & Kumar, S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0420-17.2017 · Cited by 21
“A deposits promote NMDA receptor endocytosis, and, in mice bearing a familial Swedish mutation of APP, the number of surface NMDA receptors was decreased, indicating that A can regulate the levels of NMDA receptors in neurons (Snyder et al., 2005).”
Brzdak, P., Nowak, D., Wiera, G., & Mozrzymas, J. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00178 · Cited by 21
“Although the precise mechanisms by which Aβ peptide induces LTD are not fully understood, but it is known that it depends on AMPA and NMDA receptor internalization and the disappearance of dendritic spines (Snyder et al., 2005; D’Amelio et al., 2011; Reinders et al., 2016).”
BackgroundKotagale, N. R., Deshmukh, R. A., Vinchurney, M. D., Fating, R., Umekar, M. J., & Taksande, B. G. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.013 · Cited by 23
D-Serine in Neuropsychiatric Disorders: New Advances
Durrant, A. R., & Heresco‐Levy, U. (2014) · Advances in Psychiatry · doi:10.1155/2014/859735 · Cited by 25
“In the genetic mouse model of AD, expression of surface NMDARs in neurons is decreased [158] and NMDAR-mediated response is impaired progressively with age [159, 160].”
BackgroundCulmone, V., & Migliore, M. (2012) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2012.00052 · Cited by 23
“…(Kuchibhotla et al., 2009), amyloid angiopathy (Rensink et al., 2003), and alteration in the function of N-methylD-aspartic acid (NMDA) receptors (Snyder et al., 2005; Shankar et al., 2007; Sato et al., 2008; Texidó et al., 2011) have all been reported to be affected by Aβ deposition on neuronal…”
RETRACTED ARTICLE: A needle from the haystack
Morris, R., & Mucke, L. (2006) · Nature · doi:10.1038/440284a · Cited by 25
RetractedNMDARs in Alzheimer’s Disease: Between Synaptic and Extrasynaptic Membranes
Escamilla, S., Sáez‐Valero, J., & Cuchillo‐Ibáñez, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810220 · Cited by 22
“A pioneering study in cultured cortical neurons showed that A β enhances the activity of the phosphatase STEP61, which dephosphorylates GluN2B at Tyr1472, inducing its endocytosis through clathrin adaptor proteins [43], while extrasynaptic and total NMDARs levels remained unchanged.”
BackgroundInfluentialOchiishi, T., Kaku, M., Kajsongkram, T., & Thisayakorn, K. (2021) · Genes to Cells · doi:10.1111/gtc.12889 · Cited by 29
Leo, D., Targa, G., Espinoza, S., Villers, A., Gainetdinov, R. R., & Ris, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147811 · Cited by 21
“In 2005, Snyder and colleagues demonstrated that β-amyloid can regulate the surface expression and endocytosis of NMDA-type glutamate receptors, producing a rapid and persistent depression of NMDA-evoked currents in cortical neurons [25].”
InfluentialWisniewski, M. L., Hwang, J., & Bahr, B. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.09.011 · Cited by 20
Lead (Pb) and the Risk of Alzheimer’s disease or cognitive decline: A systematic review
Loef, M., Mendoza, L. F., & Walach, H. (2011) · Toxin Reviews · doi:10.3109/15569543.2011.624664 · Cited by 22
“Since a central mechanism of Pb toxicity is the disruption of the expression of NMDA receptors and NMDARmediated calcium signaling (Toscano and Guilarte, 2005), it is possible that exposure to Pb exacerbates this mechanism in AD by increasing the Aß concentrations or by its inherent toxicity.”
Protein homeostasis in neurons and its pathological alterations
Malgaroli, A., Vallar, L., & Zimarino, V. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.009 · Cited by 25
Turano, E., Busetto, G., Marconi, S., Guzzo, F., Farinazzo, A., Commisso, M., Bistaffa, E., Angiari, S., Musumeci, S., Sotgiu, S., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.033 · Cited by 21
Malenka, R. C., & Malinow, R. (2010) · Nature · doi:10.1038/469044a · Cited by 20
NMR structure of the Arctic mutation of the Alzheimer’s Aβ(1–40) peptide docked to SDS micelles
Usachev, K. S., Filippov, A. V., Khairutdinov, B. I., Antzutkin, O. N., & Klochkov, V. V. (2014) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2014.08.030 · Cited by 21
Ma, L., Turner, D., Zhang, J., Wang, Q., Wang, M. S., Shen, J., Zhang, S., & Wu, J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.018 · Cited by 20
Epilepsy an Update on Disease Mechanisms: The Potential Role of MicroRNAs
Simonato, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00176 · Cited by 20
Age-related NMDA signaling alterations in SOD2 deficient mice
Carvajal, F. J., Mira, R. G., Rovegno, M., Minniti, A. N., & Cerpa, W. F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.019 · Cited by 21
Chang, K.-W., Zong, H.-F., Rizvi, M. Y., Ma, K., Zhai, W., Wang, M., Yang, W., Ji, S., & Qian, Y. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.107154 · Cited by 20
Metadata
- Authors
- Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., & Greengard, P.
- Affiliations
- Rockefeller University (US)
- Hospital for Sick Children (CA)
- Yale University (US)
- Cornell University (US)
- Corresponding author
- Snyder, Eric M
- Venue
- Nature Neuroscience
- Published
- 2005-07-17
- Volume
- 8
- Issue
- 8
- Pages
- 1051-1058
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1980750700
- Cited by
- 1,561
- References
- 41
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 54 · 2021: 80 · 2020: 75 · 2019: 52 · 2018: 70 · 2017: 74 · 2016: 78 · 2015: 81 · 2014: 89 · 2013: 91 · 2012: 97
- FWCI
- 50.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (01527, 52711)
- National Institute on Aging (AG09464, P01AG009464)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, NMDA receptor trafficking, receptor internalization, Alzheimer's disease, glutamatergic neurotransmission, synaptic plasticity, gamma-secretase inhibitors, alpha7 nicotinic acetylcholine receptor, calcineurin, synaptic dysfunction, cortical neurons
- MeSH terms
- Alzheimer Disease, Animals, Cell Membrane, Cerebral Cortex, Disease Models, Animal, Electric Conductivity, Endocytosis, Enzyme Activation, Neurons, Nuclear Proteins, Peptide Fragments, Receptors, Nicotinic, Synapses, Signal Transduction, Trans-Activators, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Tyrosine Phosphatases, Calcineurin, Protein Transport, CREB-Binding Protein, Mice, Protein Tyrosine Phosphatases, Non-Receptor, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.